Status:

COMPLETED

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

Lead Sponsor:

Bayer

Collaborating Sponsors:

Regeneron Pharmaceuticals

Conditions:

Wet Macular Degeneration

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to collect real-life data on patients with wet age related macular degeneration (AMD) for whom treatment with Eylea was initiated

Detailed Description

The study is both retrospective and prospective to collect local real life data on patients under routine treatment. The observation period starts on January 2014. Patients who have received the 1st i...

Eligibility Criteria

Inclusion

  • Patient with a diagnosis of wet AMD will be enrolled after the decision for treatment with Aflibercept (Eylea) has been made
  • Patient with 1st injection of Eylea from 01 January 2014 until 30 April 2015 will be enrolled
  • Prior/current treatment with any anti-VEGF intravitreal injections or macular laser (laser and/or visudyne/PDT) in the fellow eye is allowed
  • Man or woman aged 18 years or more
  • Patient who has been given appropriate information about the study objectives and procedures and who has given his/her written, informed consent;

Exclusion

  • Patient with another retinal disease: diabetic retinopathy, diabetic macular oedema (DME), myopic choroidal neovascularization, retinal vein occlusion (RVO), central serous chorioretinopathy (CSC), angioid streaks
  • Patient who does not meet the local indication criteria for Eylea treatment.Contraindications listed in the Summary of Product Characteristics (SmPC) must be taken into account
  • Patient who has previously been treated with any macular laser (laser and/or visudyne/PDT) or any anti-VEGF intravitreal injections for the study eye
  • Patient taking part in an interventional study at the time of enrolment.

Key Trial Info

Start Date :

January 2 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 17 2019

Estimated Enrollment :

593 Patients enrolled

Trial Details

Trial ID

NCT02279537

Start Date

January 2 2014

End Date

April 17 2019

Last Update

November 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Multiple Locations, France